SEMA4D and cancer: DHM has been demonstrated to significantly lower Sema4D expression in vivo and in vitro, resulting in a reduction in inflammatory invasion and limiting the expression of inflammatory factors and MDA levels in CoLo-205 colorectal cancer cells [94], reducing the risk of cancer development.